VIPoma (pancreatic cholera) crisis
Neuroendocrine · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Vasoactive intestinal peptide-secreting tumour causing profuse secretory (WDHA) diarrhoea, severe hypokalaemia, dehydration and achlorhydria.
Red flags
- Severe hypokalaemia with arrhythmia
- Profound dehydration / shock
- Metabolic acidosis
- Very high stool output
Assessment
Differential diagnosis
- Carcinoid syndrome
- Zollinger-Ellison syndrome
- Infectious secretory diarrhoea
- Laxative abuse
- Medullary thyroid carcinoma
Investigations
- U&E (marked hypokalaemia), glucose, calcium
- Blood gas (metabolic acidosis)
- Serum VIP level
- Stool volume/osmolality
- Imaging for pancreatic tumour
Management
- Resuscitate with IV fluids for severe dehydration
- Aggressively replace potassium and correct acid-base
- Control diarrhoea with somatostatin analogue
- Confirm with VIP level and tumour imaging
- Endocrinology / oncology referral
- Plan definitive tumour treatment
Drugs & doses
IV fluids and potassium replacement
Octreotide / somatostatin analogue
Correction of acidosis
Disposition
Admit; endocrinology.
Complications & pitfalls
- Cardiac arrhythmia from hypokalaemia
- Renal impairment
- Circulatory collapse
Exam pearls
- Watery diarrhoea, hypokalaemia and achlorhydria (WDHA) is the classic triad.
- Somatostatin analogues dramatically reduce stool volume.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.